Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogenic bacteria in the oral cavity refers collectively to bacterial species capable of causing oral diseases such as dental caries, gingivitis, and periodontitis. This group includes Gram-positive and Gram-negative bacteria, notably *Streptococcus mutans* and *Lactobacillus spp.* (cariogenic), and *Porphyromonas gingivalis*, *Treponema denticola*, *Tannerella forsythia*, *Fusobacterium nucleatum*, *Aggregatibacter actinomycetemcomitans*, and others associated with periodontal disease[1][3][7]. These bacteria interact with oral surfaces to form biofilms (plaque), produce acids and proteolytic enzymes that degrade host tissues, evade the immune system, and can develop antibiotic resistance[2][3][5]. Treatments target these bacteria with antibiotics, antiseptics, or probiotics, though antibiotic resistance and disruption of beneficial oral microbiota remain important safety concerns[2][3]. Clinical and molecular biomarkers can monitor their presence and the status of oral disease[1][3]. Because this entry refers to a whole group of organisms rather than a specific molecule, gene, or protein, it does not meet the criteria for a canonical molecular target, and is best considered a placeholder or umbrella term.
Inhibition of bacterial cell wall synthesis; inhibition of protein synthesis; disruption of bacterial biofilm; alteration of bacterial metabolism; and immune modulation via anti-inflammatory or anti-bacterial activity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogenic bacteria in oral cavity.